학술논문

Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy.
Document Type
Article
Source
Nature Communications; 11/2/2023, Vol. 14 Issue 1, p1-15, 15p
Subject
PROGRESSIVE supranuclear palsy
SYSTEMS biology
DRUG target
DISCOIDIN domain receptor 2
PARKINSONIAN disorders
TAUOPATHIES
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)